CSI Market
Sign In | Register

Charles River Laboratories International inc (CRL) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CRL quarterly Cash Flow →
Tracking cash flow results across Charles River Laboratories International inc to Dec 25 2021 helps illustrate how Dec 27 2025's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 27 2025)
12 Months 		(Dec 28 2024) (Dec 30 2023) (Dec 31 2022) (Dec 25 2021)
Operating Activities
Income-142.16
Depreciation & amortization403.31
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use424.08
Provision For Loan Losses Expensed6.06
Inventories Decrease /-Increase-36.33
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business-3.38
Share-based Compensation71.08
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Increase Decrease In Contract With Customer Liability-38.14
Venture Capital And Equity Method Investments Gain Loss And Impairments Net24.91
Income taxes-75.29
Gain (Loss) on Investments, Excluding Other than Temporary Impairments0.00
Accounts Receivable115.05
Increase (Decrease) in Accounts Payable2.87
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-31.57
Other Noncash Income (Expense)2.50
Other net0.00
Payments for (Proceeds from) Other Operating Activities14.65
Discontinued operations0.00
Net Cash flow from Operating Activities737.65
Investing Activities
Capital Expenditures-219.15
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities9.10
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-20.08
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets17.44
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities3.36
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-209.32
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings1,227.53
Long-term debt - repayments-1,349.32
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-359.96
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-241.41
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents205.57
Payments For Additional Equity Interests-19.14
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-536.73
Effect of exchange rate on cash flow18.83
Discontinued operations0.00
Free Cash Flow518.49
Total Cash Flow10.43
4 historic quarters locked

Sign in to unlock the full Charles River Laboratories International inc cash flow history.

Sign In Create Free Account

About Charles River Laboratories International Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251227)
  • Filed with the SEC: February 18, 2026
  • Source: crl-20251227.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001100682-26-000022

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License